studi
role
virus
atyp
bacteria
children
hospit
exacerb
asthma
prospect
studi
children
acut
asthma
admit
depart
pediatr
lill
hospit
nordpa
de
calai
region
octob
includ
children
age
year
activ
asthma
defin
three
recurr
episod
revers
wheez
sever
asthma
asthmat
exacerb
record
immunofluoresc
assay
ifa
nasopharyng
secret
np
serolog
test
use
detect
influenza
viru
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
coronaviru
polymeras
chain
reaction
pcr
assay
np
use
rhinoviru
enteroviru
serolog
test
chlamydia
pneumonia
mycoplasma
pneumonia
perform
control
group
asymptomat
asthmat
outpati
examin
respiratori
virus
use
ifa
pcr
eightytwo
symptomat
children
mean
age
year
examin
virus
detect
enteroviru
rhinoviru
rsv
serolog
test
atyp
bacteria
posit
patient
c
pneumonia
pneumonia
among
control
subject
mean
age
year
one
pcr
posit
enteroviru
correl
sever
chronic
asthma
asthmat
exacerb
diagnosi
infect
atyp
bacteri
pathogen
infect
link
prolong
asthmat
symptom
conclus
confirm
high
incid
viral
infect
acut
exacerb
asthma
especi
enterovirus
rhinovirus
persist
clinic
featur
frequent
associ
atyp
bacteri
infect
suggest
infect
investig
treat
case
persist
asthmat
symptom
asthma
common
chronic
diseas
childhood
estim
children
franc
time
sign
symptom
compat
asthma
numer
studi
suggest
preval
asthma
increas
year
understand
pathogenesi
asthma
improv
result
new
concept
asthma
chronic
inflammatori
disord
airway
control
inflammatori
compon
becom
one
import
therapeut
target
longterm
treatment
despit
improv
treatment
asthmat
crise
still
occur
result
costli
visit
hospit
link
respiratori
tract
infect
acut
exacerb
asthma
recogn
long
time
advanc
microbiolog
diagnosi
recent
studi
highlight
role
upper
respiratori
tract
virus
probabl
commonest
caus
exacerb
asthma
research
also
suggest
atyp
bacteria
chlamydia
pneumonia
mycoplasma
pneumonia
may
play
role
asthma
purpos
region
prospect
studi
investig
role
organ
acut
exacerb
asthma
children
achiev
appli
serolog
sensit
detect
techniqu
sampl
collect
period
children
asthma
exacerb
requir
hospit
hospit
nordpa
de
calai
region
examin
possibl
link
clinic
radiolog
biolog
data
presenc
viru
potenti
treatabl
atyp
bacteria
prospect
studi
perform
univers
hospit
lill
commun
hospit
nordpa
de
calai
region
franc
hospit
research
ethic
committe
approv
studi
patient
control
subject
recruit
octob
parent
gave
consent
children
particip
includ
children
age
year
activ
asthma
defin
three
recurr
episod
revers
wheez
within
year
preced
studi
children
exacerb
requir
hospit
enrol
studi
parent
gave
consent
exclud
patient
histori
chronic
lung
diseas
heart
diseas
subject
parent
ask
durat
frequenc
asthmat
symptom
medic
hospit
histori
allergi
allergi
defin
one
posit
skin
prick
test
specif
ige
inhal
allergen
clinic
featur
includ
respiratori
rate
chest
examin
associ
digest
symptom
nausea
vomit
diarrhea
abdomin
pain
record
oxymetri
peak
expiratori
flow
rate
measur
child
older
year
sever
asthma
asthmat
exacerb
score
accord
publish
guidelin
baselin
blood
sampl
nasal
swab
collect
first
hour
admiss
serolog
virolog
test
followup
visit
three
week
discharg
hospit
children
examin
new
blood
sampl
collect
convalesc
specimen
clinic
recoveri
defin
absenc
asthmat
symptom
normal
physic
examin
chest
radiograph
taken
earli
admiss
everi
patient
chest
radiograph
read
taken
radiologist
includ
asthmat
outpati
histori
exacerb
upper
respiratori
tract
infect
preced
period
clinic
investig
physician
confirm
respiratori
sign
suggest
infect
nasal
swab
collect
without
blood
sampl
nasal
secret
collect
swab
two
separ
viral
transport
medium
tube
bovin
serum
albumin
antibiot
u
penicillin
ng
streptomycin
minim
essenti
medium
mem
mg
piperazin
ethanolsulf
acid
hepe
ml
tryptos
phosphat
broth
one
tube
use
immunofluoresc
detect
assay
viral
antigen
second
frozen
transport
store
hr
follow
sampl
revers
transcriptasepolymeras
chain
reaction
rtpcr
assay
immunofluoresc
assay
ifa
cell
separ
centrifug
wash
phosphatebuff
salin
pb
load
onto
microscop
slide
fix
aceton
molecular
techniqu
appli
sampl
store
dna
total
rna
extract
simultan
ml
viral
aspir
viral
transport
medium
use
rapid
extract
protocol
silica
column
system
high
pure
viral
nucleic
acid
kit
accord
manufactur
recommend
roch
molecular
biochem
rtpcr
assay
carri
access
rtpcr
system
describ
manufactur
promega
franc
briefli
rtpcr
assay
perform
total
volum
ml
use
mg
nucleic
acid
extract
nasal
swab
mm
deoxynucleotid
triphosph
mm
mgso
iu
tfl
dna
polymeras
iu
revers
transcriptas
ml
special
buffer
amvtfl
dna
polymeras
pmol
primer
recogn
sequenc
locat
noncod
nucleotid
sequenc
human
rhinoviru
enteroviru
genom
amplif
cycl
perform
mj
research
thermocycl
watertown
usa
accord
recommend
manufactur
use
cycl
temperatur
primer
anneal
phase
rnafre
neg
control
contain
rtpcr
reaction
mix
includ
assay
genom
viral
rna
extract
pfu
coxsackieviru
human
rhinoviru
strain
atcc
purifi
cic
isopycn
ultracentrifug
use
posit
control
posit
picornaviru
rtpcr
product
pb
subject
agaros
gel
electrophoresi
ethidium
bromid
stain
analyz
hybrid
microtit
plate
digoxigeninlabel
probe
correspond
part
human
rhinoviru
noncod
nc
region
conclud
rhinoviru
present
detect
rhinoviru
rna
sequenc
posit
hybrid
enteroviru
present
detect
picornaviru
rna
sequenc
posit
without
detect
rhinoviru
rna
sequenc
leukocyt
platelet
count
creactiv
protein
level
determin
antiviru
influenza
ab
rsv
parainfluenza
adenoviru
antibodi
total
antibodi
pneumonia
assess
complement
fixat
test
eurobio
behr
virion
ltd
switzerland
diagnosi
recent
pneumonia
viral
infect
accept
increas
antibodi
titer
pair
sera
occur
antibodi
titer
second
serolog
test
neg
result
first
test
microimmunofluoresc
test
use
estim
level
igg
iga
igm
antibodi
c
pneumonia
savyon
serum
antibodi
c
pneumonia
elementari
bodi
detect
use
fluoresceinconjug
monoclon
mous
antihuman
igsubclass
antibodi
diagnosi
recent
c
pneumonia
infect
defin
igm
titer
equal
greater
igg
titer
equal
greater
titer
rise
igm
igg
presenc
iga
low
level
igg
consid
indic
chronic
infect
analyz
differ
patient
control
group
paramet
student
ttest
continu
variabl
w
test
categor
variabl
compar
infect
noninfect
patient
test
use
examin
differ
virusinfect
patient
patient
infect
atyp
bacteria
use
fisher
exact
test
categor
variabl
wilcoxon
test
continu
variabl
use
stepwis
method
select
clinic
biolog
andor
radiolog
data
link
presenc
infect
p
valu
consid
signific
valu
measur
express
mean
ae
standard
deviat
sd
one
hundr
thirteen
children
includ
studi
thirtyon
patient
attend
followup
visit
subsequ
exclud
eightytwo
patient
remain
entir
analysi
femal
male
mean
age
year
rang
year
distribut
patient
particip
time
octoberdecemb
januarymarch
apriljun
asthma
classifi
accord
criteria
third
intern
pediatr
consensu
statement
show
infrequ
episod
symptom
patient
frequent
episod
symptom
persist
symptom
allergi
note
patient
exacerb
began
hr
hospit
mean
hr
exacerb
mild
moder
sever
mean
durat
hospit
day
rang
day
radiograph
abnorm
chest
exclud
hyperinfl
present
patient
peribronchi
thicken
opac
pneumomediastinum
twentyseven
asymptomat
asthmat
outpati
femal
male
mean
age
year
rang
year
includ
control
group
statist
differ
two
group
term
sex
age
sever
asthma
tabl
leukocyt
count
determin
patient
reveal
granulocytosi
patient
neutropenia
patient
lymphopenia
patient
eosinophilia
patient
monocytosi
patient
creactiv
protein
level
high
mg
l
children
microbiolog
result
posit
children
virus
detect
patient
asthma
exacerb
tabl
four
sampl
picornavirida
pcr
assay
could
interpret
correspond
patient
count
test
enterovirus
detect
patient
rhinoviru
patient
rsv
patient
influenza
b
patient
parainfluenza
patient
adenoviru
patient
serolog
test
atyp
bacteria
posit
patient
asthmat
crisi
case
c
pneumonia
infect
pneumonia
infect
c
pneumonia
patient
posit
igm
second
serolog
suggest
recent
infect
other
two
posit
result
high
iga
igg
suggest
chronic
infect
one
also
rise
igg
two
pathogen
found
patient
rsv
rhinoviru
rsv
enteroviru
enteroviru
parainfluenza
pneumonia
parainfluenza
viru
pneumonia
enteroviru
except
one
posit
pcr
enteroviru
viru
detect
control
group
viral
detect
ifa
pcr
significantli
less
frequent
control
hospit
patient
p
compar
infect
patient
children
suffer
asthmat
exacerb
tabl
mean
age
infect
children
year
rang
year
compar
year
other
rang
year
p
statist
differ
age
sex
period
inclus
sever
asthma
inhal
steroid
longterm
treatment
crisi
sever
improv
hr
recoveri
day
fever
temperatur
higher
frequent
infect
uninfect
children
vs
p
frequenc
biolog
radiolog
abnorm
group
associ
digest
symptom
frequent
among
infect
patient
uninfect
patient
vs
p
final
compar
children
viral
infect
n
atyp
bacteri
infect
n
tabl
statist
differ
age
sex
period
inclus
sever
asthma
crisi
fever
associ
digest
disord
improv
hr
frequenc
biolog
radiolog
abnorm
group
signific
differ
lower
rate
recoveri
week
exacerb
associ
atyp
bacteri
infect
viral
infect
vs
p
studi
children
symptomat
asthma
virus
evid
viral
infect
detect
patient
evid
atyp
bacteri
infect
asthmat
patient
often
report
histori
cold
upper
respiratori
symptom
day
preced
onset
exacerb
associ
respiratori
infect
asthma
attack
also
suspect
support
epidemiolog
data
use
convent
techniqu
ifa
viru
isol
serolog
method
virus
detect
patient
asthmat
exacerb
combin
convent
molecular
techniqu
johnston
et
al
identifi
infecti
organ
patient
exacerb
asthma
commun
studi
asthmat
children
author
report
season
pattern
preval
upper
respiratori
virus
correl
close
hospit
admiss
asthma
area
cohort
drawn
final
confirm
high
frequenc
viral
infect
posit
find
infant
children
admit
hospit
sever
wheez
ill
similar
studi
year
freymuth
et
al
identifi
infecti
organ
children
age
month
year
hospit
wheez
studi
children
proven
viral
infect
popul
characterist
diagnost
method
may
explain
low
frequenc
includ
children
previou
diagnosi
asthma
histori
three
episod
wheez
exclud
children
year
age
avoid
confus
bronchiol
studi
hospit
children
johnston
et
al
includ
children
wheez
includ
bronchiol
pneumonia
freymuth
et
al
describ
criteria
use
defin
asthma
toddler
therefor
case
bronchiol
includ
studi
weak
diagnost
method
studi
absenc
pcr
detect
adenoviru
rsv
parainfluenza
coronaviru
use
previou
studi
molecular
techniqu
sensit
ifa
viral
isol
detect
virus
previous
report
commun
studi
involv
intens
monitor
children
parent
allow
earli
sampl
probabl
increas
rate
detect
virus
compar
hospitalbas
studi
fact
sever
day
may
elaps
rhiniti
cough
onset
wheez
onset
wheez
hospit
admiss
studi
delay
onset
exacerb
viral
investig
could
explain
part
lower
rate
viral
detect
use
method
final
exclus
septemb
due
delay
obtain
ethic
committe
approv
could
contribut
low
rate
virus
predominantli
detect
studi
picornavirida
repres
posit
sampl
rhinoviru
enteroviru
agreement
previou
studi
pcr
method
sensit
cell
cultur
techniqu
southampton
commun
studi
rhinovirus
detect
children
hospitalbas
studi
similar
result
report
children
older
year
detect
rate
lower
detect
rate
might
explain
variat
viral
ecolog
area
differ
sensit
assay
use
first
hypothesi
appear
unlik
rhinovirus
ubiquit
detect
preval
unit
state
finland
england
franc
detect
picornavirida
use
primer
use
similar
studi
rhinoviru
specif
identifi
freymuth
et
al
us
specif
primer
commun
studi
rhinoviru
identifi
patient
patient
picornavirus
classifi
rhinoviru
without
confirm
specif
primer
therefor
virus
may
correspond
rhinoviru
enteroviru
inde
enteroviru
frequent
detect
occur
patient
studi
freymuth
et
al
identifi
enteroviru
patient
johnston
et
al
identifi
patient
hospitalbas
studi
enteroviru
specif
identifi
commun
studi
detect
rsv
coupl
ifa
nasopharyng
secret
serolog
test
southampton
studi
studi
rsv
detect
patient
novemb
decemb
confirm
epidem
variat
viru
rsv
infect
found
princip
youngest
children
rsv
detect
rate
increas
children
less
year
old
rsv
identifi
children
older
year
studi
freymuth
et
al
use
ifa
pcr
children
hospitalbas
studi
johnston
et
al
use
ifa
cultur
serolog
communitybas
studi
older
children
ifa
cultur
serolog
detect
level
virus
influenza
parainfluenza
adenoviru
result
influenza
viru
similar
previou
studi
studi
parainfluenza
viru
alway
associ
anoth
pathogen
enteroviru
one
patient
pneumonia
adenoviru
identifi
one
patient
howev
freymuth
et
al
use
molecular
techniqu
detect
adenoviru
children
older
year
adenovir
infect
seem
play
minor
role
exacerb
asthma
final
detect
coronaviru
ifa
freymuth
et
al
identifi
viru
patient
use
ifa
johnston
et
al
identifi
cultur
molecular
amplif
virus
organ
incrimin
acut
exacerb
asthma
previou
studi
suggest
common
bacteri
infect
play
role
howev
atyp
bacteria
develop
intracellularli
c
pneumonia
pneumonia
may
associ
exacerb
asthma
dallo
baseman
demonstr
intracellular
develop
pneumonia
human
cell
cultur
report
patient
respiratori
diseas
futur
research
may
clarifi
whether
organ
gener
recogn
surfac
parasit
also
play
intracellular
role
c
pneumonia
oblig
intracellular
organ
common
respiratori
pathogen
associ
atyp
pneumonia
bronchiti
rhiniti
sinus
children
adolesc
c
pneumonia
infect
associ
wheez
children
adult
diagnosi
c
pneumonia
infect
remain
difficult
pcr
techniqu
sensit
techniqu
suscept
falseposit
diagnos
case
asymptomat
carrier
environment
contamin
serolog
test
poor
sensit
difficulti
detect
specif
igm
immunofluoresc
techniqu
delay
rise
antibodi
fact
igm
appear
week
c
pneumonia
infect
igg
week
halflif
serolog
iga
short
less
week
presenc
iga
may
correspond
persist
antigen
stimul
reflect
chronic
infect
emr
et
al
identifi
c
pneumonia
patient
cultur
serolog
test
children
exacerb
asthma
report
improv
respiratori
symptom
treatment
macrolid
cunningham
et
al
use
pcr
specif
secretori
iga
nasal
aspir
show
similar
result
asthmat
children
without
exacerb
respect
howev
patient
repeatedli
posit
pcr
high
local
iga
present
frequent
acut
exacerb
suggest
link
asthma
symptom
chronic
c
pneumonia
infect
four
c
pneumonia
serolog
test
posit
studi
three
might
suggest
chronic
infect
accord
definit
pneumonia
primari
caus
agent
communityacquir
pneumonia
children
age
year
industri
countri
common
year
age
asymptomat
carrier
infrequ
repres
posit
pcr
result
case
famili
epidem
previou
studi
detect
rate
low
exacerb
asthma
detect
four
pneumonia
infect
use
serolog
test
includ
two
dual
infect
viru
use
sensit
pcr
techniqu
freymuth
et
al
report
pneumonia
infect
patient
cunningham
et
al
studi
data
suggest
minor
role
pneumonia
exacerb
asthma
contrari
increas
antibodi
posit
ifa
result
nasal
aspir
pcr
may
detect
viru
recent
infect
also
asymptomat
carrier
latent
viral
infect
freymuth
et
al
johnston
et
al
nasal
aspir
repeat
children
differ
time
chronic
infect
detect
studi
examin
control
popul
asthmat
outpati
demograph
characterist
similar
hospit
children
one
pcr
posit
enteroviru
control
group
patient
subsequ
examin
reveal
presenc
rhiniti
time
sampl
symptom
asthma
therefor
studi
provid
support
evid
acut
infect
signific
caus
exacerb
asthma
virus
induc
asthmat
crise
two
differ
pathway
directli
infect
lower
airway
indirectli
infect
limit
upper
airway
induc
lower
airway
inflamm
immunolog
neurogen
mechan
consequ
asthma
symptom
recent
studi
shown
posit
signal
rhinoviru
bronchial
biopsi
bronchiolar
lavag
fluid
strongli
suggest
rhinoviru
replic
lower
airway
parainfluenza
influenza
virus
adenoviru
rsv
result
support
hypothesi
direct
effect
lower
respiratori
tract
although
precis
mechan
respiratori
virus
caus
symptom
unknown
evid
suggest
immun
respons
viru
play
major
role
symptom
pathogenesi
respons
complex
involv
mani
airway
cell
cytokin
mediat
like
play
key
role
process
degre
chronic
allerg
inflamm
may
influenc
type
immun
respons
viral
infect
tri
determin
featur
character
patient
infect
signific
differ
two
group
regard
sever
asthma
sever
asthma
exacerb
presenc
radiolog
infiltr
biolog
chang
paramet
statist
link
infect
presenc
digest
symptom
fever
digest
symptom
frequent
associ
respiratori
infect
especi
case
enteroviru
rhinoviru
atyp
bacteria
spite
discrimin
statist
analys
unabl
estim
predict
score
viral
atyp
bacteri
infect
characterist
patient
hospit
admiss
determin
score
would
requir
larger
studi
optim
microbiolog
assay
antibiot
treatment
may
effect
atyp
bacteri
infect
studi
initi
clinic
radiograph
featur
children
pneumonia
c
pneumonia
infect
differ
children
without
atyp
bacteri
infect
therefor
low
incid
justifi
systemat
antibiot
treatment
children
asthma
exacerb
howev
studi
suggest
atyp
bacteri
infect
link
persist
respiratori
symptom
week
onset
exacerb
pneumonia
c
pneumonia
may
contribut
persist
asthmat
symptom
poorli
control
steroid
atyp
bacteria
sought
case
infect
difficult
erad
seem
requir
prolong
use
week
macrolid
although
microbiolog
diagnosi
remain
difficult
especi
virus
atyp
bacteria
confirm
high
incid
viral
infect
acut
exacerb
asthma
atyp
bacteria
especi
c
pneumonia
incrimin
persist
asthmat
symptom
chronic
infect
investig
prolong
asthmat
symptom
poorli
control
steroid
high
incid
viral
infect
justifi
research
prevent
treatment
current
influenza
vaccin
effect
strategi
prevent
cure
viral
respiratori
infect
either
vaccin
medic
could
potenti
reduc
occurr
exacerb
asthma
improv
qualiti
life
asthmat
patient
reduc
cost
asthmat
diseas
